GPR35 activation reduces Ca2+ transients and contributes to the kynurenic acid-dependent reduction of synaptic activity at CA3-CA1 synapses
about
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice.Arrays of microLEDs and astrocytes: biological amplifiers to optogenetically modulate neuronal networks reducing light requirement.The therapeutic potential of orphan GPCRs, GPR35 and GPR55.G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation.G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease.The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities.Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.Chemical genomic analysis of GPR35 signaling.Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.Astrocytic and neuronal localization of kynurenine aminotransferase-2 in the adult mouse brain.G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35.LEFTY2 inhibits endometrial receptivity by downregulating Orai1 expression and store-operated Ca2+ entry.Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress.Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions.Relevance of Alternative Routes of Kynurenic Acid Production in the Brain.Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling
P2860
Q26770781-F730D696-9B22-484E-99DF-CF0B2B1BA7E5Q30654478-AA29123E-9E3D-493F-A5A7-A0E7D3B5CED4Q34271096-A02CF29F-E1A2-471A-8715-6C8D19660045Q35425244-F15D738F-C566-4C88-BACE-E72C9C2D1A75Q37122933-1D53DB6E-3160-47D0-8BA3-9353973901C1Q38389922-A9937F40-DB98-44E1-B22B-706ACF5A192FQ38675915-DCDDC1A4-44B7-4B49-93A1-F9256C35A4E8Q38761405-48DE8D8E-E3CB-459D-9487-5FF72D4C0226Q38829183-FF489530-0FDB-474B-86D1-A8BAA9765A2CQ39176941-D92211DF-4F6B-4FA2-AC6C-16AD039B3C9FQ39446439-3CC20AE5-751B-4A2A-BC04-86128A57DB25Q46302271-639CD895-F3EF-4CB2-9653-17FC3C954D8EQ47303939-667FF122-92EE-4FDD-B821-1F8B2DA89E52Q48158678-36EF9950-5BCF-42A4-8C2C-94D054844E23Q49328492-B4FA08D6-610A-470E-B72A-48A732C7729CQ55476415-926D258A-8F8B-410D-9F5E-B34FA510F3D6Q57069397-851719E5-526C-4EC8-A6DD-7DC2BF2F07DB
P2860
GPR35 activation reduces Ca2+ transients and contributes to the kynurenic acid-dependent reduction of synaptic activity at CA3-CA1 synapses
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@ast
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@en
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@nl
type
label
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@ast
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@en
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@nl
prefLabel
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@ast
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@en
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@nl
P2093
P2860
P1433
P1476
GPR35 activation reduces Ca2+ ...... c activity at CA3-CA1 synapses
@en
P2093
Andrea Cozzi
Dario Maratea
Flavio Moroni
Guido Mannaioni
Leonardo Cavone
Maria Sili
Roberto Narducci
P2860
P304
P356
10.1371/JOURNAL.PONE.0082180
P407
P577
2013-01-01T00:00:00Z